dactinomycin has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzai, N; Hirama, T; Kawabata, H; Masutani, H; Ohmori, M; Okuma, M; Yoshida, Y | 1 |
1 other study(ies) available for dactinomycin and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation.
Topics: Apoptosis; Calcimycin; Cell Differentiation; Dactinomycin; Dimethyl Sulfoxide; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Tretinoin; Tumor Cells, Cultured | 1994 |